<DOC>
	<DOCNO>NCT01495234</DOCNO>
	<brief_summary>This study design generate data relate patient safety , bone generate activity associate use rhBMP-2/BCP device compare autograft evaluate feasibility conduct large clinical trial patient population require spinal fusion .</brief_summary>
	<brief_title>Pilot Study rhBMP-2/BCP Patients With Spinal Degeneration With Instability Requiring Surgical Fusion</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Subject radiographically document spinal degeneration instability document presence translation &gt; = 4mm angulation &gt; = 5Â° . Subject intractable back pain respond conservative treatment investigator 's opinion , require surgical spinal fusion . Subject 's pain predominantly associate back . Subject one level involvement L3L4 , L4L5 , L5S1 . Subject 18 year age great time consent give participate study . Subject willing comply study plan sign informed consent . Subject male nonpregnant , nonnursing female . All female childbearing age must agree use adequate contraception period le 16 week follow surgery . Subject primary spinal diagnosis disorder spinal degeneration instability involve surgical level . Subject spinal stenosis condition require full laminectomy procedure . Subject previous fusion , discectomy laminectomy procedure L3L4 , L4L5 L5S1 . Subject receive drug may interfere bone metabolism within two week prior plan date spinal fusion surgery ( e.g. , steroid , methotrexate ) condition require postoperative medication interfere fusion ( e.g. , steroid , nonsteroidal antiinflammatory drug , methotrexate ) . Subject overt active infection near operative spinal region . Subject active systemic infection . Subject history autoimmune disease ( Systemic Lupus Erythematosus Dermatomyositis ) . Subject 's history include hypersensitivity protein pharmaceutical ( monoclonal antibody gamma globulin ) . Subject receive treatment investigational therapy within 28 day prior implantation surgery treatment plan 16 week follow rhBMP2/BCP implantation . The subject require electrical bone growth stimulation , allograft , bone substitute part treatment . Subject history endocrine metabolic disorder know affect osteogenesis ( e.g . Paget 's disease , renal osteodystrophy , Ehlers Danlos syndrome , osteogenesis imperfecta ) . Subject know diagnosis diabetes require treatment medication . Subject receive previous radiation therapy site fuse . Subject unwilling return require followup visit . Subject prisoner . Subject insufficient bone mass precludes surgery ( e.g. , severe osteopenia osteoporosis ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Spinal degeneration</keyword>
</DOC>